Yuling Zhou Selected Research

Chorea (Rheumatic Chorea)

12/2020

Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuling Zhou Research Topics

Disease

11	Neoplasms (Cancer) 05/2024 - 01/2002
4	Adenocarcinoma of Lung 01/2022 - 01/2020
3	Hemorrhage 01/2023 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	Infections 03/2024 - 10/2013
2	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2021
2	Blindness (Hysterical Blindness) 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2023 - 03/2016
2	Disease Progression 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 07/2021 - 06/2019
2	Adenocarcinoma 09/2020 - 06/2020
2	Chronic Hepatitis B 06/2019 - 01/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 05/2014 - 04/2012
2	Myocardial Infarction 05/2004 - 11/2003
1	Hepatitis 10/2023
1	Thrombosis (Thrombus) 01/2023
1	Pulmonary Embolism 01/2023
1	Choroidal Neovascularization 01/2023
1	Macular Degeneration (Age-Related Maculopathy) 01/2023
1	Nasopharyngeal Carcinoma 01/2023
1	Aortic Dissection 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 10/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022
1	Nasopharyngitis 01/2022
1	Gallstones (Gallstone) 01/2021
1	Cholelithiasis 01/2021
1	Chorea (Rheumatic Chorea) 12/2020
1	Cerebellar Ataxia (Dysmetria) 12/2020
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 12/2020
1	Myasthenia Gravis 12/2020
1	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 12/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 09/2020
1	Obstructive Jaundice (Cholestatic Jaundice) 09/2020
1	COVID-19 01/2020
1	Hepatitis B 06/2019
1	Rheumatoid Arthritis 04/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2018
1	Retinal Neovascularization 01/2018

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 05/2024 - 12/2020
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2022
2	CytokinesIBA 10/2023 - 04/2012
2	CrizotinibIBA 01/2022 - 09/2020
2	Peptides (Polypeptides)IBA 10/2013 - 01/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Rilpivirine (TMC-278)IBA 01/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	Endothelial Growth FactorsIBA 01/2023
1	graphene oxideIBA 01/2023
1	IntegrinsIBA 01/2023
1	Gemcitabine FDA Link 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	toripalimabIBA 10/2022
1	Albumin-Bound Paclitaxel FDA Link 04/2022
1	Carboplatin (JM8)FDA LinkGeneric 04/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	LigandsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Piwi-Interacting RNAIBA 12/2021
1	Adenosine (Adenocard)FDA LinkGeneric 07/2021
1	Matrix Metalloproteinases (MMPs)IBA 07/2021
1	CholesterolIBA 01/2021
1	AntibodiesIBA 12/2020
1	Retinaldehyde (Retinal)IBA 12/2020
1	Semaphorin-3AIBA 12/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2020
1	Capecitabine (Xeloda)FDA Link 09/2020
1	anlotinibIBA 06/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2020
1	lorlatinibIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	apatinibIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 06/2019
1	AntioxidantsIBA 04/2019
1	Sweetening Agents (Sweeteners)IBA 04/2019
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2018

Therapy/Procedure

9	Therapeutics 03/2024 - 09/2015
4	Drug Therapy (Chemotherapy) 03/2024 - 01/2020
3	Radiotherapy 01/2023 - 09/2015
2	Neoadjuvant Therapy 10/2022 - 04/2022
1	Immunotherapy 01/2023
1	Quantum Dots (Quantum Dot) 01/2023
1	Adjuvant Chemotherapy 04/2022
1	Molecular Targeted Therapy 01/2022